COMPARISON OF MEDICAL AND SURGICAL CHOLESTASIS IN PREGNANCY: A PROSPECTIVE OBSERVATIONAL STUDY
Main Article Content
Keywords
Cholestasis of pregnancy, Medical cholestasis, Surgical cholestasis, Pregnancy, Fetal outcome
Abstract
Cholestasis during pregnancy is a significant hepatobiliary disorder associated with maternal discomfort and adverse fetal outcomes. It may be classified into medical cholestasis, primarily due to functional hepatic dysfunction, and surgical cholestasis, resulting from mechanical biliary obstruction. Differentiation between the two is essential for appropriate management.
Objectives: To compare the clinical profile, laboratory parameters, imaging findings, management strategies, and maternal–fetal outcomes between medical and surgical cholestasis in pregnancy.
Materials and Methods: This prospective observational study included 50 pregnant women diagnosed with cholestasis at a tertiary care hospital. Patients were categorized into medical cholestasis (n=35) and surgical cholestasis (n=15). Clinical features, biochemical parameters, ultrasonography findings, treatment modalities, and maternal and fetal outcomes were analyzed.
Results: Medical cholestasis was more common (70%) than surgical cholestasis (30%). Pruritus was the predominant symptom in medical cholestasis, while abdominal pain and jaundice were more frequent in surgical cases. Serum bile acids and transaminases were significantly higher in medical cholestasis, whereas bilirubin and alkaline phosphatase were markedly elevated in surgical cholestasis. Adverse fetal outcomes were more frequent in medical cholestasis.
Conclusion: Medical cholestasis is more prevalent during pregnancy and is associated with higher fetal risk, while surgical cholestasis poses greater maternal morbidity. Early diagnosis and appropriate differentiation are crucial for optimizing outcomes.
References
2. Royal College of Obstetricians and Gynaecologists. Obstetric cholestasis. Green-top Guideline No. 43. London: RCOG; 2011.
3. Lee RH, Kwok KM, Ingles S, Wilson ML, Mullin P, Incerpi M, et al. Pregnancy outcomes during intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2008;199(6):1–6.
4. Bacq Y, Sapey T, Bréchot JF, Pierre F, Fignon A, Dubois F. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology. 1997;26(2):358–64.
5. Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. Hepatology. 1997;25(5):1187–9.
6. Ko CW, Beresford SA, Schulte SJ, Matsumoto AM, Lee SP. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology. 2005;41(2):359–65.
7. Jamidar PA, Beck GJ, Hoffman BJ, Hawes RH, Lehman GA. Complications of ERCP in pregnancy. Gastrointest Endosc. 1995;42(4):363–7.
8. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40(2):467–74.
9. Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014;124(1):120–33.
10. Brouwers L, Koster MP, Page-Christiaens GC, Kemperman H, Boon J, Evers IM, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol. 2015;212(1):100.e1–7.
11. Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes with intrahepatic cholestasis of pregnancy according to bile acid concentration. Lancet. 2019;393(10174):899–909.
12. Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES). Lancet. 2019;394(10201):849–60.
13. Rook M, Vargas J, Caughey AB, Bacchetti P, Rosenthal P, Bull L, et al. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. PLoS One. 2012;7(3):e28343.
14. Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64(4):933–45.
15. Society of Obstetric Medicine of Australia and New Zealand (SOMANZ). Guidelines for the management of intrahepatic cholestasis of pregnancy. Aust N Z J Obstet Gynaecol. 2023;63(1):12–25.
16. Wood AM, Livingston EG, Hughes BL, Kuller JA. Intrahepatic cholestasis of pregnancy: a review of diagnosis and management. Obstet Gynecol Surv. 2018;73(2):103–9.
17. Padmaja M, Reddy KR. Surgical causes of jaundice in pregnancy. J Clin Exp Hepatol. 2020;10(5):441–8.
18. Cappell MS, Friedel D. Abdominal pain during pregnancy. Gastroenterol Clin North Am. 2003;32(1):1–58.
19. Ahmed M, Diggory R. The management of gallstones in pregnancy. BMJ. 2011;342:d2926.
20. Laifer-Narin S, Kwak E, Kim H, Hecht EM. MR imaging of the abdomen and pelvis during pregnancy. Radiographics. 2014;34(5):1441–58.
21. Sharma A, Nagpal M, Suri V, Aggarwal N. Pregnancy outcome in women with cholestasis of pregnancy: a prospective study. Int J Gynaecol Obstet. 2019;144(2):185–9.
22. Rathi C, Poddar P, Pandey S. Cholestatic jaundice in pregnancy: a tertiary care experience from North India. J Obstet Gynaecol India. 2021;71(5):480–6.
23. Williamson C, Ovadia C. Challenges in intrahepatic cholestasis of pregnancy. Lancet. 2020;396(10265):1407–9.
24. Marschall HU, Wikström Shemer E. Intrahepatic cholestasis of pregnancy: new insights into diagnosis and management. Clin Liver Dis. 2024;28(1):145–60.
25. Li L, Zhang Y, Liu X, Chen Y. Maternal and neonatal outcomes of intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2025;25:112.

